Literature DB >> 31807520

OGTT 2-hour serum C-peptide index as a predictor of post-transplant diabetes mellitus in kidney transplant recipients.

Xingqiang Lai1, Lei Zhang1, Jiali Fang1, Guanghui Li1, Lu Xu1, Junjie Ma1, Yunyi Xiong1, Luhao Liu1, Zheng Chen1.   

Abstract

BACKGROUND: The high incidence of post-transplant diabetes mellitus (PTDM) necessitates the identification of new factors to explain its pathogenesis. This study aimed to clarify the association between the C-peptide index (CPI) and PTDM.
METHODS: A total of 290 non-diabetic kidney transplant patients were analyzed. All subjects underwent a 75 g oral glucose tolerance test (OGTT). Plasma glucose concentrations, serum C-peptide levels, hemoglobin A1c (HbA1c), and other biochemical indicators were measured. CPI was calculated as the ratio of serum C-peptide to plasma glucose.
RESULTS: Among the 290 patients, 36 (12.4%) developed PTDM at the end of 1 year. Patients with PTDM had older age (P<0.001), higher levels of body mass index (BMI) (P=0.004) and HbA1c (P=0.001), a higher proportion of deceased donors (P=0.045), and lower levels of 2 h-CPI (P=0.02) than those without PTDM. The OGTT 2 h-CPI was positively correlated with BMI, HbA1c, type of calcineurin inhibitor, albumin, and triglyceride. Multivariate logistic regression and Cox hazard model analysis showed that pre-transplant OGTT 2 h-CPI was an independent predictor for the development of PTDM, together with age, BMI, and HbA1c.
CONCLUSIONS: Of the pre-transplant factors studied, OGTT 2 h-CPI proved to be an independent predictor of PTDM. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  C-peptide index (CPI); Kidney transplantation; hemoglobin A1c (HbA1c); post-transplant diabetes mellitus (PTDM); predictor

Year:  2019        PMID: 31807520      PMCID: PMC6861761          DOI: 10.21037/atm.2019.10.14

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  28 in total

Review 1.  [Post-transplantation diabetes mellitus].

Authors:  Karine Moreau
Journal:  Nephrol Ther       Date:  2006-01       Impact factor: 0.722

2.  Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.

Authors:  Motoo Araki; Stuart M Flechner; Hazem R Ismail; Lawrence M Flechner; Lingmei Zhou; Ithaar H Derweesh; David Goldfarb; Charles Modlin; Andrew C Novick; Charles Faiman
Journal:  Transplantation       Date:  2006-02-15       Impact factor: 4.939

3.  Association of Body Mass Index and the Risk of New-Onset Diabetes After Kidney Transplantation: A Meta-analysis.

Authors:  S Chang; J Jiang
Journal:  Transplant Proc       Date:  2018-03-10       Impact factor: 1.066

4.  High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria.

Authors:  Young Min Cho; Kyong Soo Park; Hye Seung Jung; Hyun Jung Jeon; Curie Ahn; Jongwon Ha; Sang Joon Kim; Byoung Doo Rhee; Seong Yeon Kim; Hong Kyu Lee
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

Review 5.  Risk factors for new-onset diabetes after kidney transplantation.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  Nat Rev Nephrol       Date:  2010-05-25       Impact factor: 28.314

6.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

7.  Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.

Authors:  E Ishimura; S Okuno; K Kono; Y Fujino-Kato; Y Maeno; S Kagitani; N Tsuboniwa; K Nagasue; K Maekawa; T Yamakawa; M Inaba; Y Nishizawa
Journal:  Diabetes Res Clin Pract       Date:  2009-01-09       Impact factor: 5.602

8.  Functional assessment of pancreatic beta-cell area in humans.

Authors:  Juris J Meier; Bjoern A Menge; Thomas G K Breuer; Christophe A Müller; Andrea Tannapfel; Waldemar Uhl; Wolfgang E Schmidt; Henning Schrader
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

Review 9.  Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes.

Authors:  Yoshifumi Saisho
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

10.  OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus.

Authors:  Hongmei Zhang; Bingxian Bian; Fan Hu; Qing Su
Journal:  Oncotarget       Date:  2017-02-09
View more
  1 in total

1.  Blockade of OX40/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients.

Authors:  Xingqiang Lai; Zhongpeng Yao; Fen Ning; Lei Zhang; Jiali Fang; Guanghui Li; Lu Xu; Yunyi Xiong; Luhao Liu; Rongxin Chen; Junjie Ma; Zheng Chen
Journal:  Ann Transl Med       Date:  2020-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.